184 related articles for article (PubMed ID: 24885650)
21. Perceptions and Experiences of Human Papillomavirus (HPV) Infection and Testing among Low-Income Mexican Women.
León-Maldonado L; Wentzell E; Brown B; Allen-Leigh B; Torres-Ibarra L; Salmerón J; Billings DL; Thrasher JF; Lazcano-Ponce E
PLoS One; 2016; 11(5):e0153367. PubMed ID: 27149525
[TBL] [Abstract][Full Text] [Related]
22. Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada.
Sauvageau C; Duval B; Gilca V; Lavoie F; Ouakki M
BMC Public Health; 2007 Oct; 7():304. PubMed ID: 17961209
[TBL] [Abstract][Full Text] [Related]
23. Knowledge of Cervical Cancer Screening and Prevention by Human Papillomavirus Deoxyribonucleic Acid and Human Papillomavirus Vaccination among Women Attending a Tertiary Care Centre.
Amatya Vaidya S; Roka Magar L; Magar SB
JNMA J Nepal Med Assoc; 2023 Aug; 61(264):658-661. PubMed ID: 38289809
[TBL] [Abstract][Full Text] [Related]
24. Information needs among women taking part in primary HPV screening in England: a content analysis.
Marlow L; Forster AS; McBride E; Rockliffe L; Kitchener H; Waller J
BMJ Open; 2020 Dec; 10(12):e044630. PubMed ID: 33323451
[TBL] [Abstract][Full Text] [Related]
25. Understanding the role of embarrassment in gynaecological screening: a qualitative study from the ASPIRE cervical cancer screening project in Uganda.
Teng FF; Mitchell SM; Sekikubo M; Biryabarema C; Byamugisha JK; Steinberg M; Money DM; Ogilvie GS
BMJ Open; 2014 Apr; 4(4):e004783. PubMed ID: 24727360
[TBL] [Abstract][Full Text] [Related]
26. Persistent disparities of cervical cancer among American Indians/Alaska natives: Are we maximizing prevention tools?
Bruegl AS; Emerson J; Tirumala K
Gynecol Oncol; 2023 Jan; 168():56-61. PubMed ID: 36399813
[TBL] [Abstract][Full Text] [Related]
27. Cervical cancer screening program in Indonesia: is it time for HPV-DNA tests? Results of a qualitative study exploring the stakeholders' perspectives.
Ekawati FM; Listiani P; Idaiani S; Thobari JA; Hafidz F
BMC Womens Health; 2024 Feb; 24(1):125. PubMed ID: 38365690
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference.
Giorgi Rossi P; Carozzi F; Federici A; Ronco G; Zappa M; Franceschi S;
Prev Med; 2017 May; 98():21-30. PubMed ID: 27894910
[TBL] [Abstract][Full Text] [Related]
29. "Knowing that I had HPV, I literally just shut down": A qualitative exploration of the psychosocial impact of human papillomavirus (HPV) in women living with mental health conditions.
O'Donnell N; Waller J; Marlow L; Anderson NC; McBride E
Br J Health Psychol; 2024 Feb; 29(1):80-94. PubMed ID: 37658582
[TBL] [Abstract][Full Text] [Related]
30. Women's intentions to receive cervical cancer screening with primary human papillomavirus testing.
Ogilvie GS; Smith LW; van Niekerk DJ; Khurshed F; Krajden M; Saraiya M; Goel V; Rimer BK; Greene SB; Hobbs S; Coldman AJ; Franco EL
Int J Cancer; 2013 Dec; 133(12):2934-43. PubMed ID: 23754203
[TBL] [Abstract][Full Text] [Related]
31. Awareness and knowledge about HPV and primary HPV screening among women in Great Britain: An online population-based survey.
Waller J; Waite F; Marlow L
J Med Screen; 2024 Jun; 31(2):91-98. PubMed ID: 37875156
[TBL] [Abstract][Full Text] [Related]
32. Knowledge and beliefs about cervical cancer screening among men in Kumasi, Ghana.
Williams MS; Amoateng P
Ghana Med J; 2012 Sep; 46(3):147-51. PubMed ID: 23661828
[TBL] [Abstract][Full Text] [Related]
33. Relationships among health-related social media use, knowledge, worry, and cervical cancer screening: A cross-sectional study of US females.
Li J
Patient Educ Couns; 2024 Jul; 124():108283. PubMed ID: 38593482
[TBL] [Abstract][Full Text] [Related]
34. Cervical Cancer Prevention in Rural Areas.
Zhetpisbayeva I; Kassymbekova F; Sarmuldayeva S; Semenova Y; Glushkova N
Ann Glob Health; 2023; 89(1):75. PubMed ID: 37928103
[TBL] [Abstract][Full Text] [Related]
35. Using focus groups to plan culturally acceptable primary cervical cancer screening in Grenada, West Indies.
Hyacinth-Purcell C; Sylvester-Gill J; Sperr E; McPherson J; Baldwin A
Rev Panam Salud Publica; 2023; 47():e32. PubMed ID: 36726601
[TBL] [Abstract][Full Text] [Related]
36. Perceived barriers to self-collected HPV testing for cervical cancer screening, and knowledge of HPV: a survey of primary healthcare smear-takers across Aotearoa New Zealand.
Ingamells S; Bell R; Nip J; Innes C; Te Whaiti S; Tino A; McBain L; McMenamin J; Hudson B; Gibson M; Lawton B; Sykes P
N Z Med J; 2024 Feb; 137(1590):57-76. PubMed ID: 38386856
[TBL] [Abstract][Full Text] [Related]
37. The changing landscape of cervical screening-What does the future hold for primary care?
Marlow L; Waller J
Eur J Cancer Care (Engl); 2017 May; 26(3):. PubMed ID: 28436064
[TBL] [Abstract][Full Text] [Related]
38. Women's experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study.
Lee F; Bula A; Chapola J; Mapanje C; Phiri B; Kamtuwange N; Tsidya M; Tang J; Chinula L
BMC Cancer; 2021 Apr; 21(1):428. PubMed ID: 33882885
[TBL] [Abstract][Full Text] [Related]
39. Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study.
Hill E; Nemec M; Marlow L; Sherman SM; Waller J
J Med Screen; 2021 Sep; 28(3):333-340. PubMed ID: 33175638
[TBL] [Abstract][Full Text] [Related]
40. Acceptability of extending HPV-based cervical screening intervals from 3 to 5 years: an interview study with women in England.
Nemec M; Waller J; Barnes J; Marlow LAV
BMJ Open; 2022 May; 12(5):e058635. PubMed ID: 35508345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
